European elections face growing threat of organised social media manipulation
07 Jan 2019 – 11:36 | No Comment

With a new batch of MEPs, a new president of the European Council and European Central Bank, as well as new commissioners due to take up their posts in 2019, European elections face growing threat …

Read the full story »
Health

Energy & Environment

Circular Economy

Climate Change

Security

PSA testing: A more informed approach
14 Jul 2017 – 10:00

By Chris Booth, Trustee, CHAPS Men’s Health Charity
Despite continuing controversy, (1) for the foreseeable future the blood test Prostate Specific Antigen (PSA) remains the only initial, simple, cheap option available to screen for Prostate Cancer …

Future challenges for better control of prostate cancer
14 Jul 2017 – 10:00
Future challenges for better control of prostate cancer

Reducing over-diagnosis and the resulting overtreatment through refined and improved early detection is crucial in improving the quality of life and survival of prostate cancer patients. Dr Tit Albreht, Head of Centre, National Institute of …

Improve access to brachytherapy for all patients across Europe
14 Jul 2017 – 09:35
Improve access to brachytherapy for all patients across Europe

Despite brachytherapy being highly effective among prostate cancer patients, availability of facilities differs across Europe and several countries are still under-equipped. Dr Bradley Pieters, Head – Brachytherapy Department, University of Amsterdam, calls for a uniform …

Ensure patient access to next-generation cancer treatments
14 Jul 2017 – 09:31
Ensure patient access to next-generation cancer treatments

There have been several new promising therapies for prostate cancer, but many patients across Europe are not yet getting equal access to treatment. Dr Marisca Marian from Bayer calls on policy makers, researchers and key …

A radical vision to beat prostate cancer in Europe
14 Jul 2017 – 09:30
A radical vision to beat prostate cancer in Europe

An increasing trend in the incidence of prostate cancer (PCa) has been observed in almost all European countries over the last few decades. There are no population-based, organised programmes for PCa in Europe as existing …

Latest twists in PCa diagnosis and treatment
14 Jul 2017 – 09:25
Latest twists in PCa diagnosis and treatment

Prof Dr Hein Van Poppel, Adjunct Secretary General – Education, European Association for Urology, provides an overview of the latest in the fast moving field of prostate cancer diagnosis and management
Population based PSA screening has …

Integrating patient preference into treatment decisions prove crucial
14 Jul 2017 – 09:25
Integrating patient preference into treatment decisions prove crucial

Director of the European Cancer Patient Coalition, Dr Lydia Makaroff, writes that patients should be partners in their own treatments, as well as empowered to offer insights and practical recommendations to improve policy
The rates of …

Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?
14 Jul 2017 – 09:20
Recent advances in personalised medicine in lung cancer – how can the benefits be leveraged throughout Europe?

Michael Koehler, Commercial Portfolio Lead and Jason Almond, Brand Director, Oncology International Developed Markets at Pfizer discuss why it is imperative to support routine biomarker testing for lung cancer in Europe
Despite the highest mortality rates …

Elderly women with breast cancer have worse outcomes
14 Jul 2017 – 09:20
Elderly women with breast cancer have worse outcomes

Though almost half of women dying from breast cancer are aged 75 or above, the screening upper age in Europe never exceeds 75. Carole Mathelin, Vice President for Europe, International Society of Senology, et al, …

Professional groups call for action to lower the risk and mortality rate of prostate cancer
14 Jul 2017 – 09:20
Professional groups call for action to lower the risk and mortality rate of prostate cancer

Implementing prostate cancer awareness campaigns and corresponding survivorship plans, at both European and national levels, are key elements in effective healthcare strategies, but these moves have to be underpinned by a dynamic research environment and …